Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
96 participants
INTERVENTIONAL
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hearing and Vestibular Interactions in the Collection of Own Body and Sense of Self
NCT02518074
Integrative Study of Vestibular Pathology
NCT05525728
Idiopathic Bilateral Vestibulopathy: Peripheral Vestibular Disorders and Their Repercussions
NCT06476587
Interactions Between Striatum and Cerebellum in ADCY5 and PRRT2 Dystonias
NCT03481491
2BALANCE: Cognitive-motor Dual-tasking in Persons with Vestibular Disorders
NCT04126798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two parts will be performed. In the first one patients with bilateral vestibular areflexia will be compared to control subjects.
In the second the effect of vestibular stimulation on circadian rhythms will be evaluated
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Control without vestibular stimulation
No interventions assigned to this group
Bilateral areflexia
Patient with vestibular bilateral areflexia
No interventions assigned to this group
Areflexia controls
Controls for patients with vestibular bilateral areflexia, matched in sex and age
No interventions assigned to this group
vestibular stimulation
Subjects submitted to vestibular stimulation in order to improve circadian rhythms
vestibular stimulation
Physical activity and vestibular stimulation will be used in order to improve circadian rhythms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vestibular stimulation
Physical activity and vestibular stimulation will be used in order to improve circadian rhythms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate caffein uptake (2 to 3 cups a day)
* Moderate smoker (5 cigarettes a day)
* Regular sleeping habits
Exclusion Criteria
* Night workers
* Pregnancy
* Sleep or wakefulness disorders
* Progressive neurodegenerative disorders
* Progressive psychiatric disorders
* Thyroid disease
* Type 1 diabetes
* Not able to practice physical activity
* Drug or alcohol addiction during the last 6 months
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Denise, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Caen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Umr Ucbn/Inserm U1075 Comete
Caen, Basse-Normandie, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N° 11P03919 / N°11P03921
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2011-A001359-32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.